These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37405660)

  • 1. SUMO: In Silico Sequence Assessment Using Multiple Optimization Parameters.
    Evers A; Malhotra S; Bolick WG; Najafian A; Borisovska M; Warszawski S; Fomekong Nanfack Y; Kuhn D; Rippmann F; Crespo A; Sood V
    Methods Mol Biol; 2023; 2681():383-398. PubMed ID: 37405660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A library approach for the
    Arras P; Yoo HB; Pekar L; Schröter C; Clarke T; Krah S; Klewinghaus D; Siegmund V; Evers A; Zielonka S
    MAbs; 2023; 15(1):2261149. PubMed ID: 37766540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of
    Arras P; Yoo HB; Pekar L; Clarke T; Friedrich L; Schröter C; Schanz J; Tonillo J; Siegmund V; Doerner A; Krah S; Guarnera E; Zielonka S; Evers A
    Front Mol Biosci; 2023; 10():1249247. PubMed ID: 37842638
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.
    Wolf Pérez AM; Lorenzen N; Vendruscolo M; Sormanni P
    Methods Mol Biol; 2022; 2313():57-113. PubMed ID: 34478132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.
    Bailly M; Mieczkowski C; Juan V; Metwally E; Tomazela D; Baker J; Uchida M; Kofman E; Raoufi F; Motlagh S; Yu Y; Park J; Raghava S; Welsh J; Rauscher M; Raghunathan G; Hsieh M; Chen YL; Nguyen HT; Nguyen N; Cipriano D; Fayadat-Dilman L
    MAbs; 2020; 12(1):1743053. PubMed ID: 32249670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrete analysis of camelid variable domains: sequences, structures, and in-silico structure prediction.
    Melarkode Vattekatte A; Shinada NK; Narwani TJ; Noël F; Bertrand O; Meyniel JP; Malpertuy A; Gelly JC; Cadet F; de Brevern AG
    PeerJ; 2020; 8():e8408. PubMed ID: 32185102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for the computational humanization of antibodies and nanobodies.
    Gordon GL; Raybould MIJ; Wong A; Deane CM
    Front Immunol; 2024; 15():1399438. PubMed ID: 38812514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of therapeutic antibodies.
    Wang B; Gallolu Kankanamalage S; Dong J; Liu Y
    Antib Ther; 2021 Jan; 4(1):45-54. PubMed ID: 33928235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of scoring functions for antibody sequence assessment and optimization.
    Seeliger D
    PLoS One; 2013; 8(10):e76909. PubMed ID: 24204701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability.
    Bashour H; Smorodina E; Pariset M; Zhong J; Akbar R; Chernigovskaya M; Lê Quý K; Snapkow I; Rawat P; Krawczyk K; Sandve GK; Gutierrez-Marcos J; Gutierrez DN; Andersen JT; Greiff V
    Commun Biol; 2024 Jul; 7(1):922. PubMed ID: 39085379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Therapeutic Antibody Profiler for Computational Developability Assessment.
    Raybould MIJ; Deane CM
    Methods Mol Biol; 2022; 2313():115-125. PubMed ID: 34478133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment.
    Negron C; Fang J; McPherson MJ; Stine WB; McCluskey AJ
    MAbs; 2022; 14(1):2080628. PubMed ID: 35771588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blueprint for antibody biologics developability.
    Mieczkowski C; Zhang X; Lee D; Nguyen K; Lv W; Wang Y; Zhang Y; Way J; Gries JM
    MAbs; 2023; 15(1):2185924. PubMed ID: 36880643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.
    Khetan R; Curtis R; Deane CM; Hadsund JT; Kar U; Krawczyk K; Kuroda D; Robinson SA; Sormanni P; Tsumoto K; Warwicker J; Martin ACR
    MAbs; 2022; 14(1):2020082. PubMed ID: 35104168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein language models enable prediction of polyreactivity of monospecific, bispecific, and heavy-chain-only antibodies.
    Yu X; Vangjeli K; Prakash A; Chhaya M; Stanley SJ; Cohen N; Huang L
    Antib Ther; 2024 Jul; 7(3):199-208. PubMed ID: 39036071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pragmatic mAb lead molecule engineering from a developability perspective.
    Chi B; De Oliveira G; Gallagher T; Mitchell L; Knightley L; Gonzalez CC; Russell S; Germaschewski V; Pearce C; Sellick CA
    Biotechnol Bioeng; 2021 Oct; 118(10):3733-3743. PubMed ID: 33913507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
    Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
    MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive antibody search with whole spectrum black-box optimization.
    Tučs A; Ito T; Kurumida Y; Kawada S; Nakazawa H; Saito Y; Umetsu M; Tsuda K
    Sci Rep; 2024 Jan; 14(1):552. PubMed ID: 38177656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five computational developability guidelines for therapeutic antibody profiling.
    Raybould MIJ; Marks C; Krawczyk K; Taddese B; Nowak J; Lewis AP; Bujotzek A; Shi J; Deane CM
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4025-4030. PubMed ID: 30765520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of Antigen-Specific VHH Single-Domain Antibodies by Combining Animal Immunization with Yeast Surface Display.
    Roth L; Krah S; Klemm J; Günther R; Toleikis L; Busch M; Becker S; Zielonka S
    Methods Mol Biol; 2020; 2070():173-189. PubMed ID: 31625096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.